Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects.

Détails

ID Serval
serval:BIB_F7C5B93E7610
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Titre
Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects.
Périodique
Journal of Thrombosis and Haemostasis
Auteur(s)
Hulot J.S., Wuerzner G., Bachelot-Loza C., Azizi M., Blanchard A., Peyrard S., Funck-Brentano C., Gaussem P.
ISSN
1538-7836 (Electronic)
ISSN-L
1538-7836
Statut éditorial
Publié
Date de publication
2010
Volume
8
Numéro
3
Pages
610-613
Langue
anglais
Notes
Publication types: Clinical Trial ; Letter ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Mots-clé
2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage, Adult, Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors, Aryl Hydrocarbon Hydroxylases/genetics, Dose-Response Relationship, Drug, Drug Interactions, Heterozygote, Homozygote, Humans, Lansoprazole, Male, Phenotype, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/metabolism, Polymorphism, Genetic, Proton Pump Inhibitors/administration & dosage, Ticlopidine/administration & dosage, Ticlopidine/analogs & derivatives, Young Adult
Pubmed
Web of science
Création de la notice
13/03/2013 16:35
Dernière modification de la notice
20/08/2019 17:23
Données d'usage